Digene Corporation was a molecular diagnostics company with company headquarters in Gaithersburg, Maryland, U.S. Floyd Taub, M.D, founded the company in 1984 and it was incorporated in 1985.[1] In 1988, the first diagnostic test for human papillomavirus gained FDA approval; the test was ViraPap, developed by Life Technologies, which had been formed by the merger of GIBCO and Bethesda Research Laboratories in 1983. Clinical uptake was slow, and Life sold the test and associated intellectual property to Digene in 1990. It became Digene's most important product line.[2]

Founded1984; 39 years ago (1984)
Gaithersburg, Maryland, U.S.
FounderFloyd Taub
Defunct2007 (2007) (brought by Qiagen)

In 2007, Qiagen bought the company for US$1.6 billion.[3]

References edit

  1. ^ "Division of Corporations - Online Services". Archived from the original on 2011-07-21. Retrieved 2011-07-14.
  2. ^ Hogarth, Stuart; Hopkins, Michael; Rotolo, Daniele (2015). "Chapter 5: Technological Accretion in Diagnostics: HPV Testing and Cytology in Cervical Cancer Screening". Medical Innovation: Science, technology and practice. Routledge. ISBN 9781138860346.
  3. ^ "Netherlands' Qiagen buying Digene for $1.6 billion". Reuters. 2007-06-03. Retrieved 2020-05-01.